The U.S. Food and Drug Administration said on Tuesday it has approved SpringWorks Therapeutics' drug to treat a type of rare ...

Merck KGaA is in advanced negotiations to acquire U.S. biotech firm SpringWorks Therapeutics. While a deal isn't finalized, SpringWorks' share value surged following the talks. This acquisition could ...

Commonwealth Bank of Australia reported a nearly 2% rise in first-half cash earnings on Wednesday, helped by robust volume growth across its home lending and deposit products portfolio as well as a ...

Goldman Sachs cancelled a four-year-old policy to only take public companies that had two diverse board members, a ...

Walt Disney is changing its diversity, equity and inclusion (DEI) programs to focus more closely on business outcomes, ...

Toyota Motor Corp is recalling 106,061 U.S. vehicles over a brake fluid leak that can reduce braking ability and increase the ...

By Ludwig Burger and Ariane Luthi (Reuters) -Swiss pharmaceutical giant Novartis has agreed to acquire Anthos Therapeutics, a ...

Following an initial report from Reuters, Merck KGaA confirmed that it is in talks with SpringWorks for a potential ...

Keycorp CEO Chris Gorman said the bank's clients remain optimistic, despite the uncertainty created by new import tariffs.

Indian transportation fuel demand is expected to rise in the range of 6%-8% in fiscal year 2026, underpinned by rising ...

CVS Health investors will closely examine this week turnaround initiatives spearheaded by new CEO David Joyner and their ...

As SpringWorks Therapeutics nears a key regulatory decision in the U.S., the Connecticut-based cancer and rare disease ...